Grace Therapeutics (GRCE) Enterprise Value (2017 - 2026)
Grace Therapeutics (GRCE) posted Enterprise Value of $23.19 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 40.8% from $39.15 million a year earlier and down 59.5% from the prior quarter.
Grace Therapeutics (GRCE) Enterprise Value (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Enterprise Value at Grace Therapeutics was -$29.32 million; for FY2026 (ended Mar 31, 2026), it was $57.21 million, up 525.7% from FY2025.
- Annual Enterprise Value shows a five-year compound annual growth rate of 40.4% (FY2021 to FY2026).
- In prior fiscal years, Grace Therapeutics' Enterprise Value was $9.14 million in FY2025 (-1.0%), $9.23 million in FY2024, -$7.37 million in FY2023 and $1.29 million in FY2022 (-87.7%).
- The fiscal Q1 2027 figure stands as the lowest quarterly Enterprise Value since fiscal Q4 2025.
- On a year-over-year basis, Enterprise Value increased in four of the last six quarters, with growth averaging 143.8%.
- The strongest year-over-year quarter for Enterprise Value in the past five years was fiscal Q4 2026, with growth of 525.7%; the weakest was fiscal Q4 2022, with a decline of 87.7%.
- According to Business Quant data, Enterprise Value for the three prior fiscal quarters was $57.21 million (Q4 2026), $34.87 million (Q3 2026) and $25.24 million (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Grace Therapeutics | 34.02 Mn | -32.25 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.19 Mn |
| Mar 31, 2026 | 57.21 Mn |
| Dec 31, 2025 | 34.87 Mn |
| Sep 30, 2025 | 25.24 Mn |
| Jun 30, 2025 | 39.15 Mn |
| Mar 31, 2025 | 9.14 Mn |
| Dec 31, 2024 | 26.87 Mn |
| Sep 30, 2024 | 15.25 Mn |
| Jun 30, 2024 | 10.20 Mn |
| Mar 31, 2024 | 9.23 Mn |
| Dec 31, 2023 | 2.05 Mn |
| Sep 30, 2023 | -6.01 Mn |
| Jun 30, 2023 | 2.00 Mn |
| Mar 31, 2023 | -7.37 Mn |
| Dec 31, 2022 | -8.95 Mn |
| Sep 30, 2022 | -9.06 Mn |
| Jun 30, 2022 | -127,230.61 |
| Mar 31, 2022 | 1.29 Mn |
| Dec 31, 2021 | 9.48 Mn |
| Sep 30, 2021 | 14.79 Mn |
Grace Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=GRCE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();